The National Institute for Health and Care Excellence (NICE) has recently published a guidance on the management of stress urinary incontinence and pelvic organ prolapse in women.
One of the key recommendations in the guidance is to offer a complete range of non-surgical options, including lifestyle interventions, physical therapies and pharmacological treatments, before considering any surgical options to the affected patients.
Wherever use of surgical mesh/tape is warranted, patients must be completely briefed regarding the associated risks and should be offered a follow-up appointment within 6 months after surgery. The guidance also advises reporting any complications to the Medicines and Healthcare products Regulatory Agency and recording details in a national registry.
NICE has also issued patient decision aids for these conditions which have received endorsements from NHS England, The Royal College of Obstetricians and Gynaecologists (RCOG), The British Society for Urogynaecology and The British Association of Urological Surgeons (BSUG).
The RCOG and BSUG have welcomed NICE’s recommendation on offering non-surgical options before considering surgery. They have also urged healthcare professionals to be aware of the ongoing 'high vigilance' for the use of mesh and strictly follow the restrictions during the 'high vigilance' period.